This invention relates generally to masks for use in medical or other clinical applications, and more particularly to a custom fitted mask and method of forming same.
Many people experience breathing problems on a recurring basis, which often results in sleep disordered breathing (i.e. difficulty sleeping, snoring, or other more serious conditions such as obstructive sleep apnea). As technology advances, people with such breathing problems demand increased performance and comfort. Previous devices for improving a user's breathing have included custom fitted masks that help deliver air or another suitable gas to the user's nose at positive pressure to help force open the user's breathing passage and thus improve the user's breathing. However, previous masks may be relatively expensive due to the expertise often required to design, manufacture, and fit the masks to each particular user. Furthermore, previous masks have often been fitted to the user's unique bone structure and facial features rather poorly, if at all. As a result, previous masks have often failed to adequately prevent leakage from around the perimeter of the mask, have caused discomfort for users, and have been relatively ineffective in treating breathing problems such as sleep disordered breathing.
According to the present invention, problems and disadvantages associated with previous custom fitted masks and methods for forming them may be reduced or eliminated.
According to one embodiment, a custom fitted mask includes a thin sheet of deformable material that has been formed and fitted to a portion of a user's face surrounding the user's nostrils to conform substantially optimally to the user's unique facial features. The portion of the user's face includes only soft cartilaginous portions of the user's nose and portions of the user's face on either side of and below the soft cartilaginous portions of the user's nose. The portion of the user's face excludes hard bony portions of the user's nose generally above the soft cartilaginous portions of the user's nose.
According to another embodiment, a mask blank for using in forming a custom fitted mask includes a thin sheet of deformable material adapted to be transitioned from a non-deformable state into a deformable state, applied against at least a portion of a user's face surrounding the user's nostrils while the mask blank is in the deformable state, and deformed against the portion of the user's face to cause the mask blank to conform substantially optimally to the user's unique facial features to form the custom fitted mask.
Certain embodiments of the present invention may provide one or more technical advantages. For example, in certain embodiments, a custom fitted mask may be formed and fitted to a particular user relatively quickly and easily, with little expertise required on the part of the clinical professional who is forming and fitting the mask, typically resulting in improved efficiency for the clinical professional and reduced cost to the user. Also in contrast to prior masks, in certain embodiments, a custom fitted mask may be formed and fitted to a particular user so as to conform substantially optimally to the user's unique facial structure and features. As a result, the custom fitted mask of the present invention may provide improved fit, reduced leakage, increased comfort, and better performance, whether in treating breathing problems such as sleep disordered breathing or for any other suitable purpose for which the custom fitted mask is used. Certain embodiments of the present invention may provide some, all, or more of these advantages. Certain embodiments may provide one or more other advantages, one or more of which may be readily apparent to those skilled in the art based on the figures, descriptions, and claims included herein.
For a more complete understanding of the present invention and advantages thereof, reference is made to the following descriptions taken in conjunction with the accompanying drawings, in which like reference numbers indicate like features and wherein:
Mask 12 is preferably formed and fitted to the user's face so as to conform substantially optimally to the user's unique bone structure and facial features, including at least a portion of the user's nose surrounding the user's nostrils. In one embodiment, mask 12 covers only the soft cartilaginous portions of the user's nose and portions of the user's face to the sides of and below the soft cartilaginous portions of the user's nose, but does not cover the hard bony portions of the user's nose generally above the soft cartilaginous portions of the user's nose. This may allow custom fitted mask 12 to better conform to the unique shape of the user's face and, as a result of the improved fit, to provide reduced leakage, increased comfort, and better performance.
In another embodiment, as illustrated in
In another embodiment, as illustrated in
In one embodiment, mask 12 begins as a deformable mask blank made of a suitable deformable material. For example, a mask blank may include a suitable thermoplastic polymer and suitable fillers, stabilizers, coloring agents, antioxidants, antimicrobial agents, or other materials. As another example, a mask blank may include a light curing material such as the material sold under the name TRIAD by DENTSPLY INTERNATIONAL INC. Such materials are well known in various contexts to those skilled in the art.
In a more particular embodiment, a mask blank may include, possibly in addition to one or more other materials, one or more of the polycaprolactone polymers or other aliphatic polyesters that are described in U.S. Pat. Nos. 4,784,123 and 5,112,225 and product literature of UNION CARBIDE CORPORATION. One or more polycaprolactone polymers may have the formula:
where R is an aliphatic hydrocarbon and n may range between approximately 300 to approximately 650. The TONE polycaprolactone polymers are described in U.S. Pat. Nos. 4,784,123 and 5,112,225 and product literature of UNION CARBIDE CORPORATION as including homopolymers, block copolymers, graft copolymers, or other polymers containing epsilon-caprolactone. Polymerization may be initiated using a diol, for example and without limitation, ethylene glycol, diethylene glycol, neopentyl glycol, butane diol, hexane diol, or any other appropriate diol. The diol may have the formula:
HO—R—OH (2)
where R is an aliphatic hydrocarbon. Where a mask blank includes one or more polycaprolactone polymers, any suitable polycaprolactone polymer or polymers may be used. In general, polycaprolactone polymers may display desirable dimensional stability and thermoplasticity during cooling, biocompatibility, and a variety of other characteristics making them suitable for use in forming the mask blanks described herein.
In one embodiment, a mask blank may include a thin sheet of deformable material that is already contoured in the shape of a portion of a generic user's face, including at least the portion of the generic user's nose surrounding the generic user's nostrils. For example, the mask blank may be sized and shaped such that it will cover only the soft cartilaginous portions of the generic user's nose and portions of the generic user's face to the sides of and below the soft cartilaginous portions of the generic user's nose, but will not cover the hard bony-portions of the generic user's nose generally above the soft cartilaginous portions of the generic user's nose. In another embodiment, a mask blank may include a thin sheet of deformable material that is substantially flat except for a depression sufficient to accommodate a generic user's nose, including at least the portion of the generic user's nose surrounding the user's nostrils. In another embodiment, a mask blank may include a thin sheet of deformable material that is substantially flat over its entire surface and does not include any depressions. Thin sheets of an appropriate deformable material may be obtained, for example, from CHESAPEAKE MEDICAL PRODUCTS, INC. In all cases, a mask blank may include pre-formed holes positioned according to the position of a generic user's nostrils. Mask blanks may be formed using an injection molding process (i.e. deformable material is placed into an injection molding machine while in a liquid state), using a pressing process (i.e. deformable material is placed into a press while in a deformable state), or using any other suitable technique. Mask blanks may be sized for various classes of generic users, for example, large for men, medium for women, and small for children. In one embodiment, mask blanks may be mass produced quickly, inexpensively, and with high quality and uniformity. Mask blanks may include fittings 18, devices 24, or any other suitable features.
To form and fit mask 12 for a particular user using the mask blank, the mask blank is placed in a deformable state. For example, where the deformable material of the mask blank includes one or more polycaprolactone polymers, the mask blank may be heated in a microwave oven, in water or other non-solvent neutral liquid, or in any other suitable manner to between approximately 140° F. and approximately 180° F. so as to place the mask blank in a deformable state. If desired, features such as fittings 18 and devices 24 may be coupled to the mask blank at this time if such features are not already coupled to the mask blank. The deformable material may chemically bond to features such as fittings 18 and devices 24 while the mask blank is in a deformable state to produce an integral unit. While in a deformable state, the mask blank is brought in contact with the user's face, including at least a portion of the user's nose surrounding the user's nostrils. The mask blank is then pressed against or otherwise allowed to conform to the user's unique bone structure and facial features to form mask 12. As the deformable material cools and hardens, mask 12 solidifies and will retain its custom fitted shape. Before or after the deformable material solidifies into its final custom fitted shape, mask 12 is removed from the user's face and is ready for use, for example, in treating sleep disordered breathing.
As described above, mask 12 is preferably formed and fitted to the user's face so as to conform substantially optimally to the user's unique bone structure and facial features, including at least a portion of the user's nose surrounding the user's nostrils. In one embodiment, mask 12 covers only the soft cartilaginous portions of the user's nose and portions of the user's face to the sides of and below the soft cartilaginous portions of the user's nose, but does not cover the hard bony portions of the user's nose generally above the soft cartilaginous portions of the user's nose. This may allow custom fitted mask 12 to better conform to the unique shape of the user's face and, as a result of the improved fit, to provide reduced leakage, increased comfort, and better performance. In another embodiment, mask 12 covers at least a portion of the user's nose surrounding the user's nostrils (which may or may not be limited to the soft cartilaginous portions of the user's nose and portions of the user's face to the sides of and below the soft cartilaginous portions of the user's nose) and additionally covers the user's mouth to prevent leakage from the user's mouth. In another embodiment, mask 12 covers at least a portion of the user's nose surrounding the user's nostrils (which may or may not be limited to the soft cartilaginous portions of the user's nose and portions of the user's face to the sides of and below the soft cartilaginous portions of the user's nose), covers the user's mouth, and additionally covers at least a portion of the user's face below the user's chin to better secure mask 12 to the user's face.
Although mask 12 is described primarily for use in treating breathing problems such as sleep disordered breathing, the present invention contemplates mask 12 being used or for any other suitable purpose for which a custom fitted mask may be used. As just one example, mask 12 may be used in delivering anesthetics during surgery or another medical procedure.
Although the present invention has been described above in connection with several example embodiments, it should be understood that a plethora of changes, substitutions, variations, alterations, transformations, and modifications may be suggested to one skilled in the art, and it is intended that the present invention encompass such changes, substitutions, variations, alterations, transformations, and modifications as fall within the spirit and scope of the appended claims.
This application is a divisional application of U.S. application Ser. No. 10/280,803, filed Oct. 24, 2002 and entitled “Custom Fitted Mask and Method of Forming Same,” now U.S. Pat. No. 6,857,428.
Number | Name | Date | Kind |
---|---|---|---|
339334 | Searle | Apr 1886 | A |
690663 | Pratt | Jan 1902 | A |
746869 | Moulton | Dec 1903 | A |
774446 | Moulton | Nov 1904 | A |
781516 | Guthrie | Jan 1905 | A |
885196 | Steil | Apr 1908 | A |
893213 | Whiteway | Jul 1908 | A |
996783 | Moreau | Jul 1911 | A |
1076534 | Wallen | Oct 1913 | A |
1146264 | Kelly | Jul 1915 | A |
1483694 | Stukey | Feb 1924 | A |
1649664 | Carter | Nov 1927 | A |
1674336 | King | Jun 1928 | A |
1675202 | Warne | Jun 1928 | A |
1679748 | Stratton | Aug 1928 | A |
2171695 | Harper | Sep 1939 | A |
2178128 | Waite | Oct 1939 | A |
2383649 | Heidbrink | Aug 1945 | A |
2424533 | Faires | Jul 1947 | A |
2505028 | Boeger | Apr 1950 | A |
2521039 | Carpenter | Sep 1950 | A |
2521084 | Oberto | Sep 1950 | A |
2531222 | Kesling | Nov 1950 | A |
2574623 | Clyde | Nov 1951 | A |
2590118 | Oddo, Jr. | Mar 1952 | A |
2627268 | Leppich | Feb 1953 | A |
2671446 | Mann | Mar 1954 | A |
2712160 | Sterczek | Jul 1955 | A |
2833278 | Ross | May 1958 | A |
2867212 | Nunn, Jr. | Jan 1959 | A |
2882893 | Godfroy | Apr 1959 | A |
2917045 | Schildknecht et al. | Dec 1959 | A |
2977636 | McGuire | Apr 1961 | A |
3037501 | Miller | Jun 1962 | A |
3064354 | Pos | Nov 1962 | A |
3107668 | Thompson | Oct 1963 | A |
3124129 | Grossberg | Mar 1964 | A |
3132647 | Corniello | May 1964 | A |
3219033 | Wallshein | Nov 1965 | A |
3277892 | Tepper | Oct 1966 | A |
3312216 | Wallshein | Apr 1967 | A |
3321832 | Weisberg | May 1967 | A |
3330274 | Bennett | Jul 1967 | A |
3434470 | Strickland | Mar 1969 | A |
3457916 | Wolicki | Jul 1969 | A |
3513838 | Foderick et al. | May 1970 | A |
3522805 | Wallshein | Aug 1970 | A |
3658058 | Neidhart et al. | Apr 1972 | A |
3690004 | Frush | Sep 1972 | A |
3695265 | Brevik | Oct 1972 | A |
3845768 | Garrahan | Nov 1974 | A |
3854208 | Arant | Dec 1974 | A |
3864832 | Carlson | Feb 1975 | A |
3871370 | McDonald | Mar 1975 | A |
3882601 | Jahn | May 1975 | A |
3884226 | Tepper | May 1975 | A |
4016650 | Leusner et al. | Apr 1977 | A |
4026024 | Tradowsky | May 1977 | A |
4050457 | Davidson | Sep 1977 | A |
4114614 | Kesling | Sep 1978 | A |
4169473 | Samelson | Oct 1979 | A |
4182312 | Mushabac | Jan 1980 | A |
4227877 | Tureaud et al. | Oct 1980 | A |
4233972 | Hauff et al. | Nov 1980 | A |
4240420 | Riaboy | Dec 1980 | A |
4289127 | Nelson | Sep 1981 | A |
4294243 | Ernsting et al. | Oct 1981 | A |
4304227 | Samelson | Dec 1981 | A |
4345592 | Giorgini et al. | Aug 1982 | A |
4345593 | Sullivan | Aug 1982 | A |
4354489 | Riaboy | Oct 1982 | A |
4376628 | Aardse | Mar 1983 | A |
4382783 | Rosenberg | May 1983 | A |
4392490 | Mattingly et al. | Jul 1983 | A |
4397701 | Johnson et al. | Aug 1983 | A |
4433956 | Witzig | Feb 1984 | A |
4439147 | Magill et al. | Mar 1984 | A |
4439149 | Devincenzo | Mar 1984 | A |
4454090 | Saumell | Jun 1984 | A |
4454880 | Muto et al. | Jun 1984 | A |
4470413 | Warncke | Sep 1984 | A |
4495945 | Liegner | Jan 1985 | A |
4505672 | Kurz | Mar 1985 | A |
4530662 | Andersson et al. | Jul 1985 | A |
4553549 | Pope et al. | Nov 1985 | A |
4568280 | Ahlin | Feb 1986 | A |
4569342 | von Nostitz | Feb 1986 | A |
4593686 | Lloyd et al. | Jun 1986 | A |
4602905 | O'Keefe, III | Jul 1986 | A |
4639220 | Nara et al. | Jan 1987 | A |
4655213 | Rapoport et al. | Apr 1987 | A |
4668188 | Wolfenson et al. | May 1987 | A |
4669459 | Spiewak et al. | Jun 1987 | A |
4676240 | Gardy | Jun 1987 | A |
4706683 | Chilton et al. | Nov 1987 | A |
4715368 | George | Dec 1987 | A |
4721465 | Barasz | Jan 1988 | A |
4773853 | Kussick | Sep 1988 | A |
4784123 | Robeson | Nov 1988 | A |
4799500 | Newbury | Jan 1989 | A |
4856509 | Lemelson | Aug 1989 | A |
4858605 | Levy | Aug 1989 | A |
4858606 | Hamlin | Aug 1989 | A |
4862903 | Campbell | Sep 1989 | A |
4870962 | Sitnik | Oct 1989 | A |
4886056 | Simpson | Dec 1989 | A |
4892478 | Tateosian et al. | Jan 1990 | A |
4901737 | Toone | Feb 1990 | A |
4906234 | Voychehovski | Mar 1990 | A |
4919128 | Kopala et al. | Apr 1990 | A |
4932867 | Ueno | Jun 1990 | A |
4941212 | Liff | Jul 1990 | A |
4955393 | Adell | Sep 1990 | A |
4957124 | Mooney | Sep 1990 | A |
RE33442 | George | Nov 1990 | E |
5003633 | Itoh | Apr 1991 | A |
5003994 | Cook | Apr 1991 | A |
5011407 | Pelerin | Apr 1991 | A |
5018533 | Hawkins | May 1991 | A |
5026278 | Oxman et al. | Jun 1991 | A |
5028232 | Snow | Jul 1991 | A |
5040976 | Ubel, III et al. | Aug 1991 | A |
5042478 | Kopala et al. | Aug 1991 | A |
5042506 | Liberati | Aug 1991 | A |
5046512 | Murchie | Sep 1991 | A |
5052409 | Tepper | Oct 1991 | A |
5055039 | Abbatte et al. | Oct 1991 | A |
5056534 | Wright | Oct 1991 | A |
5062421 | Burns et al. | Nov 1991 | A |
5064371 | Smeltzer | Nov 1991 | A |
5065756 | Rapoport | Nov 1991 | A |
5066231 | Oxman et al. | Nov 1991 | A |
5078600 | Austin | Jan 1992 | A |
5092346 | Hays et al. | Mar 1992 | A |
5103838 | Yousif | Apr 1992 | A |
5112225 | Diesso | May 1992 | A |
5117816 | Shapiro et al. | Jun 1992 | A |
5154184 | Alvarez | Oct 1992 | A |
5154609 | George | Oct 1992 | A |
5183057 | Syrop et al. | Feb 1993 | A |
5188529 | Lüth | Feb 1993 | A |
5190457 | Schreinemakers | Mar 1993 | A |
5193532 | Moa et al. | Mar 1993 | A |
5213498 | Pelerin | May 1993 | A |
5233978 | Callaway | Aug 1993 | A |
5243971 | Sullivan et al. | Sep 1993 | A |
5245995 | Sullivan et al. | Sep 1993 | A |
5267557 | Her-Mou | Dec 1993 | A |
5267862 | Parker | Dec 1993 | A |
5277202 | Hays | Jan 1994 | A |
5280305 | Monroe et al. | Jan 1994 | A |
5284161 | Karell | Feb 1994 | A |
5313960 | Tomasi | May 1994 | A |
5316020 | Truffer | May 1994 | A |
5320533 | Lee | Jun 1994 | A |
5365945 | Halstrom | Nov 1994 | A |
5370533 | Bushnell | Dec 1994 | A |
5373859 | Forney | Dec 1994 | A |
5392773 | Bertrand | Feb 1995 | A |
5409017 | Lowe | Apr 1995 | A |
5415544 | Oxman et al. | May 1995 | A |
5427117 | Thornton | Jun 1995 | A |
5456264 | Series et al. | Oct 1995 | A |
5458137 | Axe et al. | Oct 1995 | A |
5477850 | Zegler et al. | Dec 1995 | A |
5488944 | Kennedy | Feb 1996 | A |
5503146 | Froehlich et al. | Apr 1996 | A |
5503167 | Wilson et al. | Apr 1996 | A |
5503552 | Diesso | Apr 1996 | A |
5517983 | Deighan et al. | May 1996 | A |
5537994 | Thornton | Jul 1996 | A |
5537999 | Dearman et al. | Jul 1996 | A |
5538000 | Rudolph | Jul 1996 | A |
5538014 | Wilson et al. | Jul 1996 | A |
5540223 | Starr et al. | Jul 1996 | A |
5551419 | Froehlich et al. | Sep 1996 | A |
5551872 | Mena | Sep 1996 | A |
5558090 | James | Sep 1996 | A |
RE35339 | Rapoport | Oct 1996 | E |
5560354 | Berthon-Jones et al. | Oct 1996 | A |
5562449 | Jacobs et al. | Oct 1996 | A |
5566683 | Thornton | Oct 1996 | A |
5582517 | Adell | Dec 1996 | A |
5592935 | Elstran et al. | Jan 1997 | A |
5611485 | Davis | Mar 1997 | A |
5657751 | Karr, Jr. | Aug 1997 | A |
5657752 | Landis et al. | Aug 1997 | A |
5662101 | Ogden et al. | Sep 1997 | A |
5676133 | Hickle et al. | Oct 1997 | A |
5678567 | Thornton et al. | Oct 1997 | A |
5687715 | Landis et al. | Nov 1997 | A |
5713349 | Keaney | Feb 1998 | A |
5718244 | Thornton | Feb 1998 | A |
5718500 | Vinci Guerra et al. | Feb 1998 | A |
5720280 | Elstran et al. | Feb 1998 | A |
5720302 | Belfer | Feb 1998 | A |
5724965 | Handke et al. | Mar 1998 | A |
5727544 | Miura | Mar 1998 | A |
5746201 | Kidd | May 1998 | A |
5752510 | Goldstein | May 1998 | A |
5755219 | Thornton | May 1998 | A |
5807100 | Thornton | Sep 1998 | A |
5810749 | Maas | Sep 1998 | A |
5829441 | Kidd et al. | Nov 1998 | A |
5832918 | Pantino | Nov 1998 | A |
5846082 | Thornton | Dec 1998 | A |
5887587 | Groenke | Mar 1999 | A |
5891372 | Besset et al. | Apr 1999 | A |
5954048 | Thornton | Sep 1999 | A |
5983892 | Thornton | Nov 1999 | A |
5988166 | Hayek | Nov 1999 | A |
6012455 | Goldstein | Jan 2000 | A |
6083442 | Gabilly | Jul 2000 | A |
6092521 | Miura | Jul 2000 | A |
6119694 | Correa et al. | Sep 2000 | A |
6123071 | Berthon-Jones et al. | Sep 2000 | A |
6155262 | Thornton et al. | Dec 2000 | A |
6155267 | Thornton | Dec 2000 | A |
6209542 | Thornton | Apr 2001 | B1 |
6247926 | Thornton | Jun 2001 | B1 |
6263871 | Brown et al. | Jul 2001 | B1 |
D448473 | Barnett et al. | Sep 2001 | S |
6305376 | Thornton | Oct 2001 | B1 |
6325064 | Thornton | Dec 2001 | B1 |
6374824 | Thornton | Apr 2002 | B1 |
6405729 | Thornton | Jun 2002 | B1 |
6412488 | Barnett et al. | Jul 2002 | B1 |
6464924 | Thornton | Oct 2002 | B1 |
6494206 | Bergamaschi et al. | Dec 2002 | B1 |
6516805 | Thornton | Feb 2003 | B1 |
6571798 | Thornton | Jun 2003 | B1 |
6645413 | Jacobs | Nov 2003 | B2 |
6675802 | Thornton | Jan 2004 | B1 |
6877513 | Scarberry et al. | Apr 2005 | B2 |
7077138 | Bateman et al. | Jul 2006 | B2 |
20020000230 | Gaskell | Jan 2002 | A1 |
20020129818 | Morgan et al. | Sep 2002 | A1 |
20040237965 | Bibi et al. | Dec 2004 | A1 |
20060005837 | Thornton | Jan 2006 | A1 |
20060124131 | Chandran et al. | Jun 2006 | A1 |
Number | Date | Country |
---|---|---|
7876294 | Sep 1994 | AU |
2764795 | Jun 1995 | AU |
156627 | Dec 1904 | DE |
2320501 | Nov 1974 | DE |
3543931 | Jun 1987 | DE |
3707952 | Sep 1988 | DE |
3719009 | Dec 1988 | DE |
44 38 512 | Oct 1994 | DE |
29506512 | Jul 1995 | DE |
19524534 | May 1996 | DE |
198 46 686 | Oct 1998 | DE |
0312368 | Apr 1989 | EP |
0359135 | Mar 1990 | EP |
2658725 | Feb 1990 | FR |
2 731 624 | Mar 1995 | FR |
2731624 | Sep 1996 | FR |
1569129 | Jun 1980 | GB |
WO9112777 | Sep 1991 | WO |
WO9820924 | May 1998 | WO |
WO9826736 | Jun 1998 | WO |
WO9846177 | Oct 1998 | WO |
WO 9846177 | Oct 1998 | WO |
Number | Date | Country | |
---|---|---|---|
20050016544 A1 | Jan 2005 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 10280803 | Oct 2002 | US |
Child | 10920977 | US |